scispace - formally typeset
M

Menko-Jan de Boer

Researcher at Radboud University Nijmegen

Publications -  153
Citations -  9759

Menko-Jan de Boer is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 46, co-authored 153 publications receiving 9222 citations. Previous affiliations of Menko-Jan de Boer include Radboud University Nijmegen Medical Centre.

Papers
More filters
Journal ArticleDOI

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

TL;DR: Guidelines and Expert Consensus documents aim to present management and recommendations based on all of the relevant evidence on a particular subject in order to help physicians to select the best possible management strategies for the individual patient, suffering from a specific condition, taking into account not only the impact on outcome, but also the risk benefit ratio of a particular diagnostic or therapeutic procedure.
Journal ArticleDOI

Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction

TL;DR: The findings suggest that ECG patterns reflect the effectiveness of myocardial reperfusion, and patients for whom reperfusions therapy by primary angioplasty was successful and who had normalised ST segments had limited damage to the myocardium and an excellent outlook during follow-up.
Journal ArticleDOI

Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

TL;DR: It is shown that, in patients with STEMI treated by primary angioplasty, symptom-onset-to-balloon time, but not door- to-balloons time, is related to mortality, particularly in non-low-risk patients and in the absence of preprocedural anterograde flow.
Journal ArticleDOI

Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade

TL;DR: MBG is a strong angiographic predictor of mortality in patients with TIMI 3 flow after primary angioplasty and should include both TIMi 3 flow and MBG 2 or 3 in the definition of successful reperfusion.
Journal ArticleDOI

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries.

TL;DR: Large variations in reperfusion treatment are still present across Europe, and countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusions therapy.